Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC
Robert F. Kennedy Jr., US secretary of Health and Human Services (HHS), left, and Martin Makary, commissioner of the Food and Drug Administration (FDA), in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM
- Product Code
- ILEA004880182
- Registered date
- 2025/11/06 00:00:00
- Credit
- Abaca Press / Kyodo News Images
- Media size
- 4000 × 2667 pixel
- Deployment size
- 4.47(MB)*
*File size when opened in Photoshop, etc.